CoChat
Sign Up
Cited by 6Immunotoxicology and immune responsesContact Dermatitis and AllergiesMedicine and Dermatology Studies History

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Integument

Diegel, Kelly L., Danilenko, Dimitry M., Wojcinski, Zbigniew W.·2013·Haschek and Rousseaux's Handbook of Toxicologic Pathology
DOI 10.1016/b978-0-12-415759-0.00055-8
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-415759-0.00055-8

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The skin thickness, from the epidermis to subcutaneous tissue, changes with the hair cycle, being the thickest in anagen and thinnest in telogen.

    “The skin thickness, from the epidermis to subcutaneous tissue, also changes with the hair cycle, being the thickest in anagen and thinnest in telogen (Fig. 6)9, 31.”

    From Morphological characteristics and notes of the skin in preclinical toxicity assessment (2023) · cites this paper as [9]

  • The density of hair follicles varies with species, with higher follicle densities in rodents and lower densities in humans, monkeys, and minipigs.

    “The density of hair follicles varies with species, with higher follicle densities in rodents and lower densities in humans, monkeys, and minipigs7, 9.”

    From Morphological characteristics and notes of the skin in preclinical toxicity assessment (2023) · cites this paper as [9]

  • Species differences in epidermal thickness have been reported.

    “Similar to the present results, species differences in the epidermal thickness have also been reported9, 22, 23.”

    From Morphological characteristics and notes of the skin in preclinical toxicity assessment (2023) · cites this paper as [9]

  • The hair cycle consists of three stages: anagen, catagen, and telogen.

    “The hair cycle consists of three stages: an actively growing phase (anagen), transition phase (catagen), and quiescent phase (telogen) (Fig. 6)1, 9, 12.”

    From Morphological characteristics and notes of the skin in preclinical toxicity assessment (2023) · cites this paper as [9]

  • Melanin consists of black or brown eumelanins and red or yellow pheomelanins, which cover the skin and protect the nuclear DNA from UV radiation.

    “Melanin consists of black or brown eumelanins and red or yellow pheomelanins, which cover the skin and protect the nuclear DNA from UV radiation2, 9.”

    From Morphological characteristics and notes of the skin in preclinical toxicity assessment (2023) · cites this paper as [9]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 172

  1. Ali, 1992, A literature review of dermatotoxicity, Vet. Hum. Toxicol., 34, 428
  2. Archambault, 1995, Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation, J. Invest. Dermatol., 104, 859, 10.1111/1523-1747.ep12607034 · DOI
  3. Azukizawa, 2011, Animal models of toxic epidermal necrolysis, J. Dermatol., 38, 255, 10.1111/j.1346-8138.2010.01173.x · DOI
  4. Benavides, 2009, The hairless mouse in skin research, J. Dermatol. Sci., 53, 10, 10.1016/j.jdermsci.2008.08.012 · DOI
  5. Braff, 2006, Antimicrobial peptides: an essential component of the skin defensive barrier, Curr. Top Microbiol. Immunol., 306, 91
  6. Bragulla, 2009, Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia, J. Anat., 214, 516, 10.1111/j.1469-7580.2009.01066.x · DOI
  7. Charruyer, 2011, What's new in dermatology: epidermal stem cells, G Ital. Dermatol. Venereol., 146, 57
  8. Danilenko, 2008, Review paper: preclinical models of psoriasis, Vet. Pathol., 45, 563, 10.1354/vp.45-4-563 · DOI
  9. Fitzpatrick, 1992, New histopathologic findings in drug eruptions, Dermatol. Clin., 10, 19, 10.1016/S0733-8635(18)30352-8 · DOI
  10. Gil, 2011, Is adipose tissue metabolically different at different sites?, Int. J. Pediatr. Obes., 6, 13, 10.3109/17477166.2011.604326 · DOI
  11. Hardy, 1992, The secret life of the hair follicle, Trends Genet., 8, 55, 10.1016/0168-9525(92)90350-D · DOI
  12. Homberger, 2009, The structure of the cornified claw sheath in the domesticated cat (Felis catus): implications for the claw-shedding mechanism and the evolution of cornified digital end organs, J. Anat., 214, 620, 10.1111/j.1469-7580.2009.01068.x · DOI
  13. Houben, 2007, A keratinocyte's course of life, Skin Pharmacol. Physiol., 20, 122, 10.1159/000098163 · DOI
  14. Igyarto, 2011, Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses, Immunity, 35, 260, 10.1016/j.immuni.2011.06.005 · DOI
  15. Ishida-Yamamoto, 2004, Epidermal lamellar granules transport different cargoes as distinct aggregates, J. Invest. Dermatol., 122, 1137, 10.1111/j.0022-202X.2004.22515.x · DOI
  16. Kelsh, 2004, Genetics and evolution of pigment patterns in fish, Pigment Cell Res., 17, 326, 10.1111/j.1600-0749.2004.00174.x · DOI
  17. Kobayashi, 2010, Canine follicle stem cell candidates reside in the bulge and share characteristic features with human bulge cells, J. Invest. Dermatol., 130, 1988, 10.1038/jid.2010.68 · DOI
  18. Matousek, 2002, A comparative review of cutaneous pH, Vet. Dermatol., 13, 293, 10.1046/j.1365-3164.2002.00312.x · DOI
  19. Meyer, 1978, The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig, Curr. Probl. Dermatol., 7, 39, 10.1159/000401274 · DOI · Paper page
  20. Montagna, 1971, Cutaneous comparative biology, Arch. Dermatol., 104, 577, 10.1001/archderm.1971.04000240001001 · DOI
  21. Monteiro-Riviere, 1990, Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species, J. Invest. Dermatol., 95, 582, 10.1111/1523-1747.ep12505567 · DOI
  22. Ngo, 2010, Dermatotoxicology: historical perspective and advances, Toxicol. Appl. Pharmacol., 243, 225, 10.1016/j.taap.2009.12.008 · DOI
  23. Novak, 2010, Human skin and oral mucosal dendritic cells as ‘good guys’ and ‘bad guys’ in allergic immune responses, Clin. Exp. Immunol., 161, 28, 10.1111/j.1365-2249.2010.04162.x · DOI
  24. Panchagnula, 1997, Animal models for transdermal drug delivery, Methods Find Exp. Clin. Pharmacol., 19, 335
  25. Papakostas, 2011, Nanoparticles in dermatology, Arch. Dermatol. Res., 303, 533, 10.1007/s00403-011-1163-7 · DOI
  26. Park, 2009, Cellular mechanisms regulating human melanogenesis, Cell Mol. Life Sci., 66, 1493, 10.1007/s00018-009-8703-8 · DOI
  27. Pauwels, 2010, Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science, Toxicol. Appl. Pharmacol., 243, 260, 10.1016/j.taap.2009.12.007 · DOI
  28. Pirmohamed, 2011, Phenotype standardization for immune-mediated drug-induced skin injury, Clin. Pharmacol. Ther., 89, 896, 10.1038/clpt.2011.79 · DOI
  29. Plonka, 2009, What are melanocytes really doing all day long.?, Exp. Dermatol., 18, 799, 10.1111/j.1600-0625.2009.00912.x · DOI
  30. Proksch, 2008, The skin: an indispensable barrier, Exp. Dermatol., 17, 1063, 10.1111/j.1600-0625.2008.00786.x · DOI · Paper page
  31. Ramdial, 2009, Drug-induced cutaneous pathology, J. Clin. Pathol., 62, 493, 10.1136/jcp.2008.058289 · DOI
  32. Salim, 2011, Vertebrate melanophores as potential model for drug discovery and development: a review, Cell Mol. Biol. Lett., 16, 162, 10.2478/s11658-010-0044-y · DOI
  33. Schaffer, 2001, The melanocortin-1 receptor: red hair and beyond, Arch. Dermatol., 137, 1477, 10.1001/archderm.137.11.1477 · DOI
  34. Schneider, 2009, The hair follicle as a dynamic miniorgan, Curr. Biol., 19, R132, 10.1016/j.cub.2008.12.005 · DOI · Paper page
  35. Schreder, 2010, Facing towards epidermal stem cells (Review), Int. J. Mol. Med., 26, 171
  36. Sulaimon, 2003, The biology of melanocytes, Vet. Dermatol., 14, 57, 10.1046/j.1365-3164.2003.00327.x · DOI
  37. Toebak, 2009, Dendritic cells: biology of the skin, Contact Dermatitis, 60, 2, 10.1111/j.1600-0536.2008.01443.x · DOI
  38. Tolleson, 2005, Human melanocyte biology, toxicology, and pathology, J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 23, 105, 10.1080/10590500500234970 · DOI
  39. Vanbokhoven, 2011, p63, a story of mice and men, J. Invest. Dermatol., 131, 1196, 10.1038/jid.2011.84 · DOI
  40. Aihara, 2011, Pharmacogenetics of cutaneous adverse drug reactions, J. Dermatol., 38, 246, 10.1111/j.1346-8138.2010.01196.x · DOI
  41. Alaluf, 2002, The impact of epidermal melanin on objective measurements of human skin colour, Pigment. Cell Res., 15, 119, 10.1034/j.1600-0749.2002.1o072.x · DOI · Paper page
  42. Alguire, 1998, Skin biopsy techniques for the internist, J. Gen. Intern. Med., 13, 46, 10.1046/j.1525-1497.1998.00009.x · DOI
  43. Andersen, 1987, Testing for contact allergy in experimental animals, Pharmacol. Toxicol., 61, 1, 10.1111/j.1600-0773.1987.tb01762.x · DOI
  44. Auletta, 2004, Current in vivo assays for cutaneous toxicity: local and systemic toxicity testing, Basic. Clin. Pharmacol. Toxicol., 95, 201, 10.1111/j.1742-7843.2004.pto950501.x · DOI
  45. Baak, 2002, The framework of pathology: good laboratory practice by quantitative and molecular methods, J. Pathol., 198, 277, 10.1002/path.1233 · DOI
  46. Benavides, 2009, The hairless mouse in skin research, J. Dermatol. Sci., 53, 10, 10.1016/j.jdermsci.2008.08.012 · DOI
  47. Forster, 2010, The minipig as a platform for new technologies in toxicology, J. Pharmacol. Toxicol. Methods, 62, 227, 10.1016/j.vascn.2010.05.007 · DOI
  48. Collan, 1998, Alternatives for morphometric and stereologic analysis in toxicopathology, Toxicol. Lett., 102–103, 393, 10.1016/S0378-4274(98)00239-2 · DOI
  49. Corcuff, 1993, Morphometry of human epidermis in vivo by real-time confocal microscopy, Arch. Dermatol. Res., 285, 475, 10.1007/BF00376820 · DOI
  50. CRL (Charles River Laboratories) Technical Sheet, 2009, The 3T3 Neutral Red Uptake, in vitro Photoirritation Test
  51. Evans, 2003, Pharmacogenomics – drug disposition, drug targets, and side effects, N. Engl. J. Med., 348, 538, 10.1056/NEJMra020526 · DOI
  52. Farage, 2011, Historical perspective on the use of visual grading scales in evaluating skin irritation and sensitization, Contact Dermatitis, 65, 65, 10.1111/j.1600-0536.2011.01912.x · DOI
  53. Forster, 2010, The minipig as a platform for new technologies in toxicology, J. Pharmacol. Toxicol. Methods, 62, 227, 10.1016/j.vascn.2010.05.007 · DOI
  54. Fullerton, 2002, Skin irritation typing and grading based on laser Doppler perfusion imaging, Skin Res. Technol., 8, 23, 10.1034/j.1600-0846.2002.80105.x · DOI
  55. Gambichler, 2006, Epidermal thickness assessed by optical coherence tomography and routine histology: preliminary results of method comparison, J. Eur. Acad. Dermatol. Venereol., 20, 791, 10.1111/j.1468-3083.2006.01629.x · DOI
  56. Gardiner, 2006, Pharmacogenetics, drug-metabolizing enzymes, and clinical practice, Pharmacol. Rev., 58, 521, 10.1124/pr.58.3.6 · DOI
  57. Helman, 1986, Acute dermal toxicity: in vivo and in vitro comparisons in mice, Fundam. Appl. Toxicol., 7, 94, 10.1016/0272-0590(86)90201-0 · DOI
  58. ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use), http://www.ich.org/, (last accessed May 2012).
  59. Jacobs, 2004, CDER photosafety guidance for industry, Toxicol. Pathol., 32, 17, 10.1080/01926230490463821 · DOI
  60. Jacobs, 2002, An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures, Toxicol. In Vitro, 16, 581, 10.1016/S0887-2333(02)00039-5 · DOI
  61. Jirova, 2010, Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data, Contact Dermatitis, 62, 109, 10.1111/j.1600-0536.2009.01640.x · DOI
  62. Kao, 1983, Quantitation of cutaneous toxicity: an in vitro approach using skin organ culture, Toxicol. Appl. Pharmacol., 68, 206, 10.1016/0041-008X(83)90005-4 · DOI
  63. Kligman, 1998, A hairless mouse model for assessing the chronic toxicity of topically applied chemicals, Food Chem. Toxicol., 36, 867, 10.1016/S0278-6915(98)00045-3 · DOI
  64. Klotz, 2007, The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications, Clin. Pharmacokinet., 46, 271, 10.2165/00003088-200746040-00001 · DOI
  65. Koehler, 2010, In vivo measurement of the human epidermal thickness in different localizations by multiphoton laser tomography, Skin. Res. Technol, 16, 259
  66. Liebsch, 2002, Currently available in vitro methods used in the regulatory toxicology, Toxicol. Lett., 127, 127, 10.1016/S0378-4274(01)00492-1 · DOI
  67. Lovell, 1992, Phototoxicity testing in guinea-pigs, Food Chem. Toxicol., 30, 155, 10.1016/0278-6915(92)90151-A · DOI
  68. Lynch, 2011, Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry, Exp. Toxicol. Pathol., 63, 209, 10.1016/j.etp.2009.12.001 · DOI
  69. Mahl, 2006, The minipig in dermatotoxicology: methods and challenges, Exp. Toxicol. Pathol., 57, 341, 10.1016/j.etp.2006.03.004 · DOI · Paper page
  70. Makinen, 1997, Quinolone antibacterials: a new class of photochemical carcinogens, J. Photochem. Photobiol. B., 37, 182, 10.1016/S1011-1344(96)07425-8 · DOI
  71. Masters, 2001, Confocal microscopy and multi-photon excitation microscopy of human skin in vivo, Opt. Express, 8, 2, 10.1364/OE.8.000002 · DOI
  72. Maurer, 1987, Phototoxicity testing – in vivo and in vitro, Food Chem. Toxicol., 25, 407, 10.1016/0278-6915(87)90177-3 · DOI
  73. Mogensen, 2008, Morphology and epidermal thickness of normal skin imaged by optical coherence tomography, Dermatology, 217, 14, 10.1159/000118508 · DOI
  74. Morton, 1998, Importance of species selection in drug toxicity testing, Toxicol. Lett., 102–103, 545, 10.1016/S0378-4274(98)00263-X · DOI
  75. Nemecek, 1999, Safety evaluation of human living skin equivalents, Toxicol. Pathol., 27, 101, 10.1177/019262339902700118 · DOI
  76. Netzlaff, 2005, The human epidermis models EpiSkin®, SkinEthic® and EpiDerm®: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport, Eur. J. Pharm. Biopharm., 60, 167, 10.1016/j.ejpb.2005.03.004 · DOI
  77. Nixon, 1975, Interspecies comparisons of skin irritancy, Toxicol. Appl. Pharmacol., 31, 481, 10.1016/0041-008X(75)90272-0 · DOI
  78. Nouveau-Richard, 2004, In vivo epidermal thickness measurement: ultrasound vs. confocal imaging, Skin Res. Technol., 10, 136, 10.1111/j.1600-0846.2004.00067.x · DOI
  79. Olson, 2000, Concordance of the toxicity of pharmaceuticals in humans and in animals, Regul. Toxicol. Pharmacol., 32, 56, 10.1006/rtph.2000.1399 · DOI · Paper page
  80. O’Rielly, 2011, Pharmacogenetics of psoriasis, Pharmacogenomics, 12, 87, 10.2217/pgs.10.166 · DOI
  81. Phillips, 1972, A comparison of rabbit and human skin response to certain irritants, Toxicol. Appl. Pharmacol., 21, 369, 10.1016/0041-008X(72)90157-3 · DOI
  82. Pincelli, 2009, Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy, Exp. Dermatol., 18, 337, 10.1111/j.1600-0625.2009.00852.x · DOI
  83. Randall, 2007, The demonstration of immunohistochemical biomarkers in methyl methacrylate-embedded plucked human hair follicles, Toxicol. Pathol., 35, 952, 10.1080/01926230701748198 · DOI
  84. Rogers, 2002, Improved method for in vitro assessment of dermal toxicity for volatile organic chemicals, Toxicol. Lett., 135, 125, 10.1016/S0378-4274(02)00207-2 · DOI
  85. Ryan, 2001, Approaches for the development of cell-based in vitro methods for contact sensitization, Toxicol. In Vitro, 15, 43, 10.1016/S0887-2333(00)00059-X · DOI
  86. Selby, 1955, An electron microscope study of the epidermis of mammalian skin in thin sections. I. Dermo-epidermal junction and basal cell layer, J. Biophys. Biochem. Cytol., 1, 429, 10.1083/jcb.1.5.429 · DOI
  87. Simon, 2000, The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations–an overview, Skin Pharmacol. Appl. Skin Physiol., 13, 229, 10.1159/000029928 · DOI
  88. Sokol, 1978, Scanning electron microscopy of skin window cells of normal subjects, J. Anat., 126, 157
  89. Stern, 1998, Photocarcinogenicity of drugs, Toxicol. Lett., 102–103, 389, 10.1016/S0378-4274(98)00237-9 · DOI
  90. Sueki, 2000, Hairless guinea pig skin: anatomical basis for studies of cutaneous biology, Eur. J. Dermatol., 10, 357
  91. Svendsen, 2006, The minipig in toxicology, Exp. Toxicol. Pathol., 57, 335, 10.1016/j.etp.2006.03.003 · DOI
  92. Swindle, 2012, Swine as models in biomedical research and toxicology testing, Vet. Pathol., 49, 344, 10.1177/0300985811402846 · DOI
  93. Wolff, 1976, Trends in electron microscopy of skin, J. Invest. Dermatol., 67, 39, 10.1111/1523-1747.ep12512480 · DOI
  94. Zhu, 2007, Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring, Wound Repair Regen., 15, S32, 10.1111/j.1524-475X.2007.00223.x · DOI
  95. Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J. Immunol., 174, 3695, 10.4049/jimmunol.174.6.3695 · DOI · Paper page
  96. Boniface, 2007, Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation, J. Immunol., 178, 4615, 10.4049/jimmunol.178.7.4615 · DOI
  97. Danilenko, 2012, The yin and yang of immunomodulatory biologics: assessing the delicate balance between benefit and risk, Toxicol. Pathol., 40, 272, 10.1177/0192623311430237 · DOI
  98. Faller, 2002, Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics, Toxicol. In Vitro, 16, 557, 10.1016/S0887-2333(02)00053-X · DOI
  99. Kandárová, 2005, EpiDerm skin irritation test protocol-Assessment of the performance of the optimised test, Altern. Lab. Anim., 33, 351, 10.1177/026119290503300408 · DOI
  100. Kandárová, 2006, Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431, Toxicol. In Vitro, 20, 547, 10.1016/j.tiv.2005.11.008 · DOI
  101. Nograles, 2008, Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways, Br. J. Dermatol., 159, 1092
  102. Sa, 2007, The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis, J. Immunol., 178, 2229, 10.4049/jimmunol.178.4.2229 · DOI
  103. Schäfer-Korting, 2008, The use of reconstituted human epidermis for skin absorption testing: Results of the validation study, Altern. Lab. Anim., 36, 161, 10.1177/026119290803600207 · DOI
  104. Semlin, 2011, In vitro models for human skin disease, Drug Discov. Today, 16, 132, 10.1016/j.drudis.2010.12.001 · DOI
  105. Bellón, 2011, The innate immune system in delayed cutaneous allergic reactions to medications, Curr. Opin. Allergy Clin. Immunol., 11, 292, 10.1097/ACI.0b013e3283489c2c · DOI
  106. Bos, 1986, The skin immune system (SIS): Its cellular constituents and their interactions, Immunol. Today, 7, 235, 10.1016/0167-5699(86)90111-8 · DOI
  107. Danilenko, 1996, Growth factors in hair follicle development and cycling: recent insights from animal models and the potentials for clinical therapy, Mol. Med. Today, 2, 460, 10.1016/1357-4310(96)10045-9 · DOI
  108. Di Meglio, 2011, The multitasking organ: recent insights into skin immune function, Immunity, 35, 857, 10.1016/j.immuni.2011.12.003 · DOI
  109. Epstein, 2008, Basal cell carcinomas: attack of the hedgehog, Nat. Rev. Cancer, 8, 743, 10.1038/nrc2503 · DOI
  110. Grachtchouk, 2011, Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations, J. Clin. Invest., 121, 1768, 10.1172/JCI46307 · DOI
  111. Harr, 2010, Toxic epidermal necrolysis and Stevens-Johnson syndrome, Orphanet. J. Rare. Dis., 5, 39, 10.1186/1750-1172-5-39 · DOI
  112. Hussein, 2005, Ultraviolet radiation and skin cancer: molecular mechanisms, J. Cutan. Pathol., 32, 191, 10.1111/j.0303-6987.2005.00281.x · DOI
  113. Lynch, 2007, Mouse skin models for carcinogenesis hazard identification: utilities and challenges, Toxicol. Pathol, 53, 853, 10.1080/01926230701748131 · DOI
  114. Ma, 2008, IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation, J. Clin. Invest., 118, 597
  115. Mecklenburg L., Kusewitt D., Kolly C., Treumann S.,, Adams E.T., Diegel K, Yamate J., Kaufmann W., Müller S., Danilenko D., Bradley A. Proliferative and non-proliferative lesions of the rat and mouse integument. INHAND initiative. Toxicol. Pathol. (in press).
  116. Nestle, 2009, Skin immune sentinels in health and disease, Nat. Rev. Immunol., 9, 679, 10.1038/nri2622 · DOI
  117. Nickoloff, 2006, Keratinocytes regain momentum as instigators of cutaneous inflammation, Trends Mol. Med., 12, 102, 10.1016/j.molmed.2006.01.001 · DOI
  118. Nograles, 2008, Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways, Br. J. Dermatol., 159, 1092
  119. Ohyama, 2007, Hair follicle bulge: A fascinating reservoir of epithelial stem cells, J. Dermatol. Sci., 46, 81, 10.1016/j.jdermsci.2006.12.002 · DOI
  120. Pritchard, 2003, The role of transgenic mouse models in carcinogen identification, Environ. Health Perspect., 111, 444, 10.1289/ehp.5778 · DOI
  121. Proksch, 2008, The skin: an indispensable barrier, Exp. Dermatol., 17, 1063, 10.1111/j.1600-0625.2008.00786.x · DOI · Paper page
  122. Ramot, 2009, Inflammatory and chloracne-like skin lesions in B6C3F1 mice exposed to 3,3′,4,4′-tetrachloroazobenzene for 2 years, Toxicology, 265, 1, 10.1016/j.tox.2009.08.017 · DOI
  123. Rho, 2011, Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis, Mol. Carcinog., 50, 264, 10.1002/mc.20665 · DOI
  124. Salmon, 1994, The skin as an immune organ, West J. Med., 160, 146
  125. Sharov, 2004, Fas signaling in the control of hair follicle response to chemotherapy, Cancer Res., 64, 6266, 10.1158/0008-5472.CAN-04-1367 · DOI
  126. Sonnenberg, 2011, Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22, Nat. Immunol., 12, 383, 10.1038/ni.2025 · DOI
  127. Strellein, 1983, Skin-associated lymphoid tissues (SALT): origins and functions, J. Invest. Dermatol., 80, 12S, 10.1111/1523-1747.ep12536743 · DOI
  128. Strid, 2009, Skin immune surveillance by T cells – a new order?, Semin. Immunol., 21, 110, 10.1016/j.smim.2009.03.002 · DOI
  129. Sugita, 2007, Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin, Clin. Exp. Immunol., 147, 176, 10.1111/j.1365-2249.2006.03258.x · DOI
  130. Youssef, 2010, Identification of the cell lineage at the origin of basal cell carcinoma, Nat. Cell Biol., 12, 299, 10.1038/ncb2031 · DOI
  131. Bellón, 2011, The innate immune system in delayed cutaneous allergic reactions to medications, Curr. Opin. Allergy Clin. Immunol., 11, 292, 10.1097/ACI.0b013e3283489c2c · DOI
  132. Danilenko, 1995, Growth factors in porcine full and partial thickness burn repair, Am. J. Pathol., 147, 1261
  133. Friedmann, 2010, Drug-induced exanthemata: a source of clinical and intellectual confusion, Eur. J. Dermatol., 20, 255, 10.1684/ejd.2010.0891 · DOI
  134. Guiducci, 2010, Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9, J. Exp. Med., 207, 2931, 10.1084/jem.20101048 · DOI
  135. Harr, 2010, Toxic epidermal necrolysis and Stevens-Johnson syndrome, Orphanet. J. Rare. Dis., 5, 39, 10.1186/1750-1172-5-39 · DOI
  136. Iwahashi, 2009, Analysis of mechanisms of T-2 toxicity using yeast DNA microarrays, Intl. J. Mol. Sci., 9, 2585, 10.3390/ijms9122585 · DOI
  137. Maruani, 2008, Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows and prediction of outcome, Am. J. Clin. Pathol., 130, 369, 10.1309/3CAKPEU8JXGWLEDC · DOI
  138. Ramdial, 2009, Drug-induced cutaneous pathology, J. Clin. Pathol., 62, 493, 10.1136/jcp.2008.058289 · DOI
  139. Segal, 2007, Cutaneous reactions to drugs in children, Pediatrics, 120, e1082, 10.1542/peds.2005-2321 · DOI
  140. Williams, 2009, Anti-TNF-induced lupus, Rheumatology, 48, 716, 10.1093/rheumatology/kep080 · DOI
  141. Brendler-Schwaab, 2004, Photochemical genotoxicity: principles and test methods. Report of a GUM task force, Mutat. Res., 566, 65, 10.1016/S1383-5742(03)00052-8 · DOI
  142. Ferguson, 2002, Photosensitivity due to drugs, Photodermatol. Photoimmunol. Photomed, 18, 262, 10.1034/j.1600-0781.2002.02778.x · DOI
  143. Forbes, 1977, Phototoxicity testing of fragrance raw materials, Food Cosmet. Toxicol., 15, 55, 10.1016/S0015-6264(77)80264-2 · DOI
  144. Gocke, 1998, The photomutagenicity of fluoroquinolones and other drugs, Toxicol. Lett., 102–103, 375, 10.1016/S0378-4274(98)00235-5 · DOI
  145. Kadekaro, 2003, Cutaneous photobiology. The melanocyte vs the sun: who will win the final round?, Pigment. Cell Res., 16, 434, 10.1034/j.1600-0749.2003.00088.x · DOI
  146. Langner, 1977, Dermal toxicity of 8-methoxypsoralen administered (by gavage) to hairless mice irradiated with long-wave ultraviolet light, J. Invest. Dermatol., 69, 451, 10.1111/1523-1747.ep12511300 · DOI
  147. Makinen, 1997, Quinolone antibacterials: a new class of photochemical carcinogens, J. Photochem. Photobiol. B, 37, 182, 10.1016/S1011-1344(96)07425-8 · DOI
  148. Shimoda, 1993, Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice, Toxicol. Pathol., 21, 554, 10.1177/019262339302100606 · DOI
  149. Stern, 1998, Photocarcinogenicity of drugs, Toxicol. Lett., 102–103, 389, 10.1016/S0378-4274(98)00237-9 · DOI
  150. Struwe, 2008, Detection of photogenotoxicity in skin and eye in rat with the photo comet assay, Photochem. Photobiol. Sci., 7, 240, 10.1039/b715756h · DOI
  151. van Kranen, 2005, Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice, Mutat. Res., 571, 81, 10.1016/j.mrfmmm.2004.07.018 · DOI
  152. Bolognia, 1988, Biology of hypopigmentation, J. Am. Acad. Dermatol., 19, 217, 10.1016/S0190-9622(88)70168-1 · DOI
  153. Briganti, 2003, Chemical and instrumental approaches to treat hyperpigmentation, Pigment. Cell Res., 16, 101, 10.1034/j.1600-0749.2003.00029.x · DOI
  154. Costin, 2007, Human skin pigmentation: melanocytes modulate skin color in response to stress, FASEB. J, 21, 976, 10.1096/fj.06-6649rev · DOI · Paper page
  155. Fistarol, 2010, Disorders of pigmentation, J. Dtsch. Dermatol. Ges., 8, 187, 10.1111/j.1610-0387.2009.07137.x · DOI
  156. Fulk, 1984, Primary disorders of hyperpigmentation, J. Am. Acad. Dermatol., 10, 1, 10.1016/S0190-9622(84)80032-8 · DOI
  157. Hendrix, 1992, Cutaneous hyperpigmentation caused by systemic drugs, Int. J. Dermatol, 31, 458, 10.1111/j.1365-4362.1992.tb02689.x · DOI
  158. Hirobe, 2011, How are proliferation and differentiation of melanocytes regulated?, Pigment. Cell Melanoma. Res., 24, 462, 10.1111/j.1755-148X.2011.00845.x · DOI
  159. Ito, 1987, Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds, J. Invest. Dermatol., 88, 77, 10.1111/1523-1747.ep12465072 · DOI
  160. Ito, 1987, Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy, Cancer Res., 47, 3278
  161. Kasraee, 2002, Depigmentation of brown guinea pig skin by topical application of methimazole, J. Invest. Dermatol., 118, 205, 10.1046/j.0022-202x.2001.01621.x · DOI
  162. Katagiri, 2001, Inhibitory action of 4-n-butylresorcinol (Rucinol) on melanogenesis and its skin whitening dffects, J. Soc. Cosmet. Chem. Jpn., 35, 42, 10.5107/sccj.35.42 · DOI
  163. Ono, 2003, Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in vivo, J. Pharm. Pharmacol., 55, 1647, 10.1211/0022357022340 · DOI
  164. Ruiz-Maldonado, 1997, Post inflammatory hypopigmentation and hyperpigmentation, Semin. Cutan. Med. Surg., 16, 36, 10.1016/S1085-5629(97)80034-X · DOI
  165. Solano, 2006, Hypopigmenting agents: an updated review on biological, chemical and clinical aspects, Pigment. Cell Res., 19, 550, 10.1111/j.1600-0749.2006.00334.x · DOI
  166. Vachiramon, 2011, Post inflammatory hypopigmentation, Clin. Exp. Dermatol., 36, 708, 10.1111/j.1365-2230.2011.04088.x · DOI
  167. Walsh, 1989, Hypopigmentation in dogs treated with an inhibitor of platelet aggregation, Toxicol. Pathol., 17, 549, 10.1177/019262338901700310 · DOI
  168. Yamaguchi, 2009, Physiological factors that regulate skin pigmentation, Biofactors, 35, 193, 10.1002/biof.29 · DOI
  169. Ramot, 2009, Inflammatory and chloracne-like skin lesions in B6C3F1 mice exposed to 3,3′,4,4′-tetrachloroazobenzene for 2 years, Toxicology, 265, 1, 10.1016/j.tox.2009.08.017 · DOI
  170. Sharov, 2004, Fas signaling in the control of hair follicle response to chemotherapy, Cancer Res., 64, 10.1158/0008-5472.CAN-04-1367 · DOI
  171. Trüeb, 2009, Chemotherapy-induced alopecia, Semin. Cutan. Med. Surg., 28, 11, 10.1016/j.sder.2008.12.001 · DOI
  172. Zouboulis, 2009, Sebaceous gland receptors, Dermatoendocrinol., 1, 77, 10.4161/derm.1.2.7804 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Diegel, K. L., Danilenko, D. M., & Wojcinski, Z. W.
Affiliations
Genentech (US)
ORCID
Danilenko, Dimitry M.
Venue
Haschek and Rousseaux's Handbook of Toxicologic Pathology
Publisher
Elsevier
Published
2013
Pages
2219-2275
DOI
10.1016/b978-0-12-415759-0.00055-8
OpenAlex
W3021314379
Cited by
6
References
3
Citations by year
2024: 2 · 2023: 1 · 2022: 1 · 2019: 1 · 2016: 1
FWCI
0.63
Type
book chapter
Language
en
Open access
closed
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Health Sciences › Medicine › Dermatology › Medicine and Dermatology Studies History
Keywords
skin, integument, toxicologic pathology, jaundice, ultraviolet radiation, chemical exposure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review